Business Wire

TRON-DAO

Share
Justin Sun Wins the Bid for All "Twelve Digital Zodiac Heads"

TRON founder Justin Sun has recently purchased the complete set of the crypto artworks "Twelve Digital Zodiac Heads" at the Twelve Digital Zodiac Heads Special Auction hosted by Metapoly XM, a brand under Poly Auction (Xiamen).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220403005114/en/

The "Twelve Digital Zodiac Heads" is the one and only NFT art collection that draws inspiration from China's Zodiac Heads, which was purchased on March 31 at a hammer price of around ¥9,832,500. Shortly after the auction, Justin Sun stated to the public that he would donate this collection in the future for a broader audience to enjoy. It is also believed that one of the animal heads in this collection will soon be listed on APENFT Marketplace for auction and introduced as rare, special-breed horses into WIN NFT HORSE, a horse racing game co-launched by TRON, the APENFT Foundation, and WINKLink.

The twelve zodiac animals are an epitome of Chinese folk culture and the unique philosophy of the Chinese nation. According to traditional Chinese culture, every newborn is assigned an auspicious animal based on their birth year. These animals are unchangeable marks that follow each Chinese throughout their life. They serve as a bond to maintain the national feelings and the Chinese culture. And of all the physical embodiment of these symbols, the Twelve Old Summer Palace bronze heads are the most precious.

Gathering the twelve bronze heads in the metaverse marks another major endeavor made by digital technology, represented by blockchain, in the cultural and art sphere. In the context of social informatization and digitization, digital propagation and protection of traditional culture will embrace wider applications in order to reproduce time-honored artworks in the digital world and diversify people's experience in art appreciation.

As a trailblazer in digital technology, Justin Sun also has serious clout in the realm of top-notch art collections. Through clinching a myriad of artworks created both by art masters and emerging digital artists on major trading platforms, Justin has managed to build an empire incorporating art, investment, finance, and more. His collections include works by Pablo Picasso, Andy Warhol, Giacometti, Beeple, and Pak, the latter two being the two most valuable crypto artists worldwide. In addition, Justin Sun has donated a number of well-known works, including Le Nez and Femme nue couchée au collier(Marie-Thérèse) , to organizations such as the APENFT Foundation to support the development of digital art.

APENFT is backed by the underlying technology of top-notch blockchains TRON with support from the world's largest distributed storage system Bittorrent File System (BTFS), dedicated to promoting the creator economy and fostering the integration of finance, culture and art in Metaverse. Its APENFT Marketplace, based on the TRON, will also be launched shortly.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Crexendo and NUSO Partner to Deliver Global Cloud Communications Capabilities23.10.2025 15:15:00 CEST | Press release

NUSO, a leading provider of cloud communications service delivery, today announced it has been chosen by Crexendo®, Inc. (NASDAQ:CXDO), an award-winning software technology company that is a premier provider of cloud communication platform software and unified communication as a service (UCaaS) offerings, including voice, video, contact center, and managed IT services tailored to businesses of all sizes, to be a preferred carrier for the Crexendo cloud communications platform. The expanded partnership allows Crexendo platform licensees to offer cloud communications capabilities over NUSO’s global delivery network, unlocking new revenue opportunities for service providers. With NUSO’s carrier footprint in more than 40 countries, the Crexendo platform now offers global service delivery with industry-leading call quality, uptime, and emergency calling compliance. Platform providers can now offer global service delivery to over 6 million end users worldwide who rely on Crexendo’s Netsapien

SK pharmteco Boosts Domestic Peptide Scale-Up with Investment in California Facility23.10.2025 15:03:00 CEST | Press release

Expansion leverages proprietary chromatography expertise to overcome purification bottlenecks and secure domestic API manufacturing capacity SK pharmteco, a global contract development and manufacturing organization (CDMO), announced today a $6.1 million investment in its Rancho Cordova facility to expand and equip a new lab and CGMP-Kilo-scale facility for Solid-Phase Peptide Synthesis (SPPS) and purification. This expansion, combined with SK pharmteco’s industry-leading chromatography expertise and existing development and manufacturing capabilities in the United States, positions the company to meet the rising demand for U.S. peptide development and domestic clinical and commercial manufacturing. "The investment in our California facility represents a key milestone in our strategic growth and demonstrates an unwavering dedication to the domestic biopharma sector,” said Joerg Ahlgrimm, CEO of SK pharmteco. “Peptides are a vital and rapidly advancing therapeutic category. This project

Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK® at the North American Cystic Fibrosis Conference23.10.2025 15:00:00 CEST | Press release

- Data presented on outcomes following treatment with CFTR modulators add to growing body of evidence that reduced level of sweat chloride is associated with improved clinical outcomes, particularly in younger people with cystic fibrosis - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the presentation of multiple abstracts demonstrating the clinical benefits of treatment with CFTR modulators, including the Company’s most recently approved medicine, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), at the North American Cystic Fibrosis Conference (NACFC) held from October 22-25 in Seattle, Washington. Several of the abstracts that will be presented at this year’s conference demonstrate that improvement in CFTR function, as measured by reduction in sweat chloride (SwCl), is associated with improved outcomes in people with cystic fibrosis (CF). ALYFTREK has shown greater reductions in sweat chloride compared to TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor

Boomi Recognized as an Exemplary Vendor in the ISG Buyers Guides™ for Data Integration and Master Data Management 202523.10.2025 15:00:00 CEST | Press release

Boomi earns top rankings across product capability, validation, and customer experience in dual Buyers Guides from ISG Software Research Boomi™, the leader in AI-driven automation, today announced it has been named an Exemplary Vendor in both the ISG Buyers Guide™ for Data Integration and the ISG Buyers Guide™ for Master Data Management 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251023515342/en/ Boomi Recognized as an Exemplary Vendor in the ISG Buyers Guides™ for Data Integration and Master Data Management 2025 In these independently published reports from ISG Software Research, a division of ISG (Information Services Group), Boomi was recognized as a Leader across multiple evaluation dimensions, including Product Experience, Capability, Customer Experience, and Validation. Customer Experience and Validation The ISG Buyers Guide™ assessments are widely used by enterprise technology buyers to evaluate market-leadin

CWAN and J.P. Morgan Asset Management Launch Automated Cash Management Solution for Hedge Funds23.10.2025 15:00:00 CEST | Press release

New integration connects Enfusion by CWAN and Morgan Money® to optimize yield, diversification, and liquidity control for hedge fund clients Clearwater Analytics (NYSE: CWAN), the most comprehensive technology platform for investment management, and J.P. Morgan Asset Management today announced an integration that transforms how hedge funds manage cash. The solution links Enfusion by CWAN directly with the Morgan Money® trading platform, J.P. Morgan Asset Management’s short-term investment management solution, giving clients a single, automated workflow for investing and monitoring idle cash. Through this connection, hedge funds can now: Maximize idle cash by automatically investing in a diversified range of money market funds. Reduce concentration risk by spreading cash across multiple managers, custodians, and currencies. Improve liquidity visibility through real-time data and automated withdrawal and deposit capabilities. Eliminate manual treasury work, freeing teams to focus on trad

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye